Medimpact Healthcare Systems, Inc.

Medimpact Healthcare Systems, Inc. company information, Employees & Contact Information

Updated May 2026

Quick answer

Medimpact Healthcare Systems, Inc. is a Hospitals and Health Care company and founded in 1989. It has approximately 1,866 employees on record. Contact data was last refreshed in May 2026. Find Medimpact Healthcare Systems, Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

MedImpact is the nation’s largest independent health solutions and pharmacy benefit company, serving commercial health plans, government programs, self insured/employer groups, and millions of consumers. Every year, we invest, innovate, develop, and partner to offer a broad suite of health and wellness solutions that deliver for our clients: - Greater clarity over their healthcare and benefits - More connected, coordinated, and effective care - Greater transparency and clinical focus to control cost - Greater flexibility, freedom, and choices - Members who are more informed, empowered, and engaged Founded 35 years ago, MedImpact is headquartered in San Diego with offices across the US and internationally.

Company Details

Employees
1.87K
Founded
-
Address
Medimpact Healthcare Systems, Inc.,
Phone
858-566-2727
Email
in****@****act.com
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
HQ
San Diego, CA
Looking for a particular Medimpact Healthcare Systems, Inc. employee's phone or email?

Medimpact Healthcare Systems, Inc. Questions

News

MedImpact Offers Low Cost, Unbranded Ustekinumab-aekn Biosimilar to Any Specialty Pharmacy in the US - Business Wire

MedImpact Offers Low Cost, Unbranded Ustekinumab-aekn Biosimilar to Any Specialty Pharmacy in the US Business Wire

MedImpact Unveils Refreshed Corporate Identity - Yahoo Finance

MedImpact Unveils Refreshed Corporate Identity Yahoo Finance

Litigation, Launch, and Lower Costs: 3 Big Moves in the US Biosimilar Space - Center for Biosimilars

Litigation, Launch, and Lower Costs: 3 Big Moves in the US Biosimilar Space Center for Biosimilars

MedImpact offering low cost Stelara biosimilar to specialty pharmacies - Drug Store News

MedImpact offering low cost Stelara biosimilar to specialty pharmacies Drug Store News

MedImpact Includes MedEmpower Fuel™ Health and Wellness App as a Standard Part of Pharmacy Benefit Services - Business Wire

MedImpact Includes MedEmpower Fuel™ Health and Wellness App as a Standard Part of Pharmacy Benefit Services Business Wire

MedImpact Expands Access to Two Biosimilars for Stelara - Yahoo Finance

MedImpact Expands Access to Two Biosimilars for Stelara Yahoo Finance

MedImpact Expands Leadership Team to Advance Its Vision to Transform Pharmacy Benefits and Offer Clients a Modular Portfolio of Connected Healthcare Solutions - Business Wire

MedImpact Expands Leadership Team to Advance Its Vision to Transform Pharmacy Benefits and Offer Clients a Modular Portfolio of Connected Healthcare Solutions Business Wire

New prescription benefits contract to yield ‘modest’ initial savings to state - Maryland Matters

New prescription benefits contract to yield ‘modest’ initial savings to state Maryland Matters

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar - Managed Healthcare Executive

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar Managed Healthcare Executive

Rite Aid defeats MedImpact in $200 million Elixir sale dispute - Reuters

Rite Aid defeats MedImpact in $200 million Elixir sale dispute Reuters

MedImpact, GoodRx team on new prescription savings program - Fierce Healthcare

MedImpact, GoodRx team on new prescription savings program Fierce Healthcare

GoodRx, MedImpact Launch Medication Savings Solution - MedCity News

GoodRx, MedImpact Launch Medication Savings Solution MedCity News

MedImpact Unveils MedEmpower Fuel™ AI Plate Scanner - Business Wire

MedImpact Unveils MedEmpower Fuel™ AI Plate Scanner Business Wire

Eye on Pharma: EC Approved Ustekinumab; Zymfentra Expansion; Biosimilar Policy Briefing - Center for Biosimilars

Eye on Pharma: EC Approved Ustekinumab; Zymfentra Expansion; Biosimilar Policy Briefing Center for Biosimilars

MedImpact’s MedEmpower Fuel™ Receives PBMI Excellence Award - Business Wire

MedImpact’s MedEmpower Fuel™ Receives PBMI Excellence Award Business Wire

MedImpact Investment in Bayvrio Accelerates Development and Launch of Groundbreaking Healthcare Solutions Marketplace - Business Wire

MedImpact Investment in Bayvrio Accelerates Development and Launch of Groundbreaking Healthcare Solutions Marketplace Business Wire

MedImpact Completes Integration of Elixir Solutions - Business Wire

MedImpact Completes Integration of Elixir Solutions Business Wire

MedImpact’s First-of-Its-Kind Solution Integrates Prescription Coverage With Third-Party Discount Programs to Reduce Drug Costs for Both Plans and Members - Business Wire

MedImpact’s First-of-Its-Kind Solution Integrates Prescription Coverage With Third-Party Discount Programs to Reduce Drug Costs for Both Plans and Members Business Wire

MedImpact Launches Holistic, Personalized Condition Management Solution - Business Wire

MedImpact Launches Holistic, Personalized Condition Management Solution Business Wire

MedImpact Acquires Elixir Solutions - Business Wire

MedImpact Acquires Elixir Solutions Business Wire

MedImpact Sues Pharmacy Network Over Threat to Curtail Contract - Bloomberg Law News

MedImpact Sues Pharmacy Network Over Threat to Curtail Contract Bloomberg Law News

GoodRx, MedImpact partner on automatic drug discounts - Healthcare Dive

GoodRx, MedImpact partner on automatic drug discounts Healthcare Dive

MedImpact Acquires Elixir Solutions - citybiz

MedImpact Acquires Elixir Solutions citybiz

Rite Aid gets court approval for $575M Elixir sale to MedImpact - Axios

Rite Aid gets court approval for $575M Elixir sale to MedImpact Axios

Rite Aid Fights $200 Million Bill After MedImpact Buys Elixir - Bloomberg.com

Rite Aid Fights $200 Million Bill After MedImpact Buys Elixir Bloomberg.com

Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute - Yahoo Finance

Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute Yahoo Finance

Rite Aid Completes Sale of Elixir Solutions to MedImpact - Business Wire

Rite Aid Completes Sale of Elixir Solutions to MedImpact Business Wire

Patient With MS Sues J&J Over ERISA Violation - Center for Biosimilars

Patient With MS Sues J&J Over ERISA Violation Center for Biosimilars

Qilin claims large pharmacy benefit manager MedImpact - Cybernews

Qilin claims large pharmacy benefit manager MedImpact Cybernews

Health In Tech's New Partnership Promises Instant Insurance Quotes for 20M+ Members - Stock Titan

Health In Tech's New Partnership Promises Instant Insurance Quotes for 20M+ Members Stock Titan

Court Approves Rite Aid’s Sale of Elixir PBM to MedImpact - Managed Healthcare Executive

Court Approves Rite Aid’s Sale of Elixir PBM to MedImpact Managed Healthcare Executive

Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Medimpact Healthcare Systems, Inc., for Alleged Wrongful Termination - PR Newswire

Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Medimpact Healthcare Systems, Inc., for Alleged Wrongful Termination PR Newswire

Winning bidder on Iowa Medicaid contract wants its proposal kept secret - The Des Moines Register

Winning bidder on Iowa Medicaid contract wants its proposal kept secret The Des Moines Register

Rite Aid Completes Sale of Elixir Solutions - Managed Healthcare Executive

Rite Aid Completes Sale of Elixir Solutions Managed Healthcare Executive

Rite Aid Wins $200 Million Dispute Over Elixir Sale to MedImpact - Bloomberg.com

Rite Aid Wins $200 Million Dispute Over Elixir Sale to MedImpact Bloomberg.com

Rite Aid Completes $576 Million PBM Sale To MedImpact - Forbes

Rite Aid Completes $576 Million PBM Sale To MedImpact Forbes

Rite Aid Completes The Sale Of Elixir Solutions To MedImpact For About $576.5 Million - Pulse 2.0

Rite Aid Completes The Sale Of Elixir Solutions To MedImpact For About $576.5 Million Pulse 2.0

Rite Aid Sells PBM Elixir For $575M To MedImpact - Forbes

Rite Aid Sells PBM Elixir For $575M To MedImpact Forbes

Court approves Rite Aid sale of Elixir Solutions PBM - Modern Healthcare

Court approves Rite Aid sale of Elixir Solutions PBM Modern Healthcare

MedImpact Wins Contract To Manage Pharmacy Benefits At UM - CBS News

MedImpact Wins Contract To Manage Pharmacy Benefits At UM CBS News

Entity linked to health care mogul drops $31M on Seaway condos in Surfside - The Real Deal

Entity linked to health care mogul drops $31M on Seaway condos in Surfside The Real Deal

A pharmacy startup is alleging its former business partner is a 'peddler of opioids' - businessinsider.com

A pharmacy startup is alleging its former business partner is a 'peddler of opioids' businessinsider.com

MedImpact Announces Layoffs - San Diego Business Journal

MedImpact Announces Layoffs San Diego Business Journal

MedImpact Expands Corporate HQ at Scripps Ranch - Connect CRE

MedImpact Expands Corporate HQ at Scripps Ranch Connect CRE

BioPlus Specialty Pharmacy Selected by MedImpact as One of Its ChoiceSpecialty® Pharmacies - PRWeb

BioPlus Specialty Pharmacy Selected by MedImpact as One of Its ChoiceSpecialty® Pharmacies PRWeb

Qilin Ransomware Claims Another Health Provider, MedImpact Healthcare Systems Targeted in Cyberattack - TechNadu

Qilin Ransomware Claims Another Health Provider, MedImpact Healthcare Systems Targeted in Cyberattack TechNadu

Top Medimpact Healthcare Systems, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant